Purpura Fulminans: a Rare but Fierce Presentation of Pneumococcal Sepsis

Adeel Nasrullah1, Anam Javed2, Usman Tariq1

  • 1Department of Internal Medicine, Allegheny Health Network; Pittsburgh, USA.

Insights

Infectious purpura fulminans (PF), a rare DIC complication, can be fatal. Early recognition of PF, often linked to pneumococcal sepsis, is crucial for timely treatment and improved outcomes.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Dermatology

Background:

  • Infectious purpura fulminans (PF) is a rare, life-threatening condition characterized by disseminated intravascular coagulopathy (DIC), leading to skin thrombosis and hemorrhagic infarction.
  • PF commonly arises from sepsis due to bacteria like *Neisseria meningitidis*, *Streptococcus pneumoniae*, and *Haemophilus influenzae*, presenting with skin lesions, fever, and hypotension.
  • Despite aggressive treatment, PF carries a high mortality rate of 43%.

Purpose of the Study:

  • To present a case of PF secondary to DIC caused by pneumococcal sepsis in an immunocompetent patient.
  • To highlight the critical importance of early recognition and prompt therapeutic intervention in managing infectious purpura fulminans.
  • To contribute to the limited knowledge regarding the management of PF, exploring potential therapeutic modalities.

Main Methods:

  • Case report presentation of a patient with infectious purpura fulminans.
  • Review of clinical presentation, diagnostic findings, and treatment course.
  • Discussion of the pathophysiology linking pneumococcal sepsis to DIC and PF.

Main Results:

  • The case illustrates PF as a complication of DIC secondary to *Streptococcus pneumoniae* sepsis.
  • The patient presented with characteristic ecchymotic skin lesions, fever, and hypotension, indicative of PF.
  • The report emphasizes that a characteristic skin rash is a key diagnostic clue for PF.

Conclusions:

  • Infectious purpura fulminans is a hematological emergency requiring immediate recognition and treatment to mitigate severe morbidity and mortality.
  • Prompt initiation of therapy based on clinical suspicion, particularly a characteristic rash, is vital, as delays for diagnostic confirmation can be detrimental.
  • Further research is needed to establish evidence-based management protocols, as the efficacy of therapies like hyperbaric oxygen and IVIG remains uncertain due to a lack of prospective data.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
428
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
720
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
308
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
383
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
656